ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.4400
-0.0200 (-4.35%)
At close: Mar 28, 2025, 4:00 PM
0.4491
+0.0091 (2.07%)
Pre-market: Mar 31, 2025, 4:11 AM EDT

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $13.30 million as of March 28, 2025. Its market cap has decreased by -85.40% in one year.

Market Cap
13.30M
Enterprise Value
42.39M
1-Year Change
-85.40%
Ranking
Category
Stock Price
$0.44

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $13.30M, a decrease of -85.54%. That is a compound annual growth rate of -7.08%.

History

DateMarket Cap% Change
Mar 28, 202510.50M-41.99%
Dec 31, 202418.10M-77.82%
Dec 29, 202381.60M-47.96%
Dec 30, 2022156.80M41.01%
Dec 31, 2021111.20M4.41%
Dec 31, 2020106.50M367.11%
Dec 31, 201922.80M-37.36%
Dec 31, 201836.40M34.81%
Dec 29, 201727.00M-21.05%
Dec 30, 201634.20M33.59%
Dec 31, 201525.60M13.27%
Dec 31, 201422.60M-11.72%
Dec 31, 201325.60M26.73%
Dec 31, 201220.20M19.53%
Dec 30, 201116.90M-3.98%
Dec 31, 201017.60M-30.98%
Dec 31, 200925.50M-50.58%
Dec 31, 200851.60M-15.69%
Dec 31, 200761.20M-15.24%
Dec 29, 200672.20M-55.24%
Dec 30, 2005161.30M64.42%
Dec 31, 200498.10M-19.85%
Dec 31, 2003122.40M94.29%
Dec 31, 200263.00M156.10%
Dec 31, 200124.60M179.55%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 738.61B
UnitedHealth Group 472.03B
Johnson & Johnson 394.52B
AbbVie 363.15B
Novo Nordisk 305.46B
AstraZeneca 229.16B
Abbott Laboratories 226.88B
Merck & Co. 225.40B
Market Cap Rankings